Nuvation Bio INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
Nuvation Bio Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for May 21, 2026, to elect directors, ratify auditors, and vote on executive compensation.
NYSE
Nuvation Bio is holding its annual meeting of stockholders on May 21, 2025, to vote on director elections, auditor ratification, and executive compensation.
NYSE
Nuvation Bio issues a supplement to its proxy statement to clarify voting approval standards for the proposals at the Annual Meeting of Stockholders on September 3, 2024.
NYSE
Nuvation Bio is holding its annual meeting on September 3, 2024, to vote on director elections, auditor ratification, executive compensation, preferred stock conversion, and a potential meeting adjournment.